Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
10 decrease » _ decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 10 » _ 10 (Expand Search), x 10 (Expand Search), 1 1 (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
10 decrease » _ decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 10 » _ 10 (Expand Search), x 10 (Expand Search), 1 1 (Expand Search)
-
881
-
882
-
883
-
884
-
885
-
886
-
887
-
888
-
889
-
890
Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer
Published 2025“…We have therefore generated additional derivatives which have improved mitochondrial complex 1 inhibition and reduced PDE10A inhibition. Two of these compounds were tested <i>in vivo</i> for radiosensitization of murine EO771 mammary gland tumors and found to be as effective as papaverine with an improved safety profile.…”
-
891
Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer
Published 2025“…We have therefore generated additional derivatives which have improved mitochondrial complex 1 inhibition and reduced PDE10A inhibition. Two of these compounds were tested <i>in vivo</i> for radiosensitization of murine EO771 mammary gland tumors and found to be as effective as papaverine with an improved safety profile.…”
-
892
-
893
-
894
-
895
-
896
-
897
-
898
Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study
Published 2015“…</p><p>Setting</p><p>Women aged 60 years and older in 2005, from 21 primary care centers in a healthcare region of Spain.</p><p>Participants</p><p>Two groups of women aged 60 years and older (n = 1208), prescribed either calcium and vitamin D (CalVitD) or bisphosphonates (BIPHOS) with or without calcium and vitamin D, were compared for the end point of first recorded osteoporotic-related fracture, with 5-years follow-up.…”
-
899
-
900